Clinical Trial: Clairleaf??: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
Study Status: Completed
Recruit Status: RECRUITING
Condition: Bronchiectasis
Study Type: INTERVENTIONAL
Official Title: A Randomised, Double-blind, Parallel Group, Roll-over Study Evaluating Long-term Safety and Efficacy of Oral Doses of BI 1291583 q.d. in Patients With Bronchiectasis ((Clairleaf??)
Brief Summary:
This study is open to adults aged 18 years and older with bronchiectasis.People can join the study if they were previously enrolled in another study with BI 1291583 (1397-0012: Airleaf??).The purpose of this study is to find out whether a medicine called BI 1291583 helps people with bronchiectasis, an inflammatory lung condition.The investigators also want to know how well people with this condition can tolerate BI 1291583 in the long term.Participants take a low, medium, or high dose of BI 1291583 as a tablet…
Read more